Patrick McIlvenny's most recent trade in Horizon Therapeutics Plc was a trade of 11,498 Restricted Stock Units (RSU) done . Disclosure was reported to the exchange on Jan. 4, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Plc | Patrick McIlvenny | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 11,498 | 11,498 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Patrick McIlvenny | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 7,973 | 10,463 (0%) | 0% | - | Ordinary Shares | |
| Horizon Therapeutics Plc | Patrick McIlvenny | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 113.24 per share. | 04 Jan 2023 | 4,147 | 6,316 (0%) | 0% | 113.2 | 469,606 | Ordinary Shares |
| Horizon Therapeutics Plc | Patrick McIlvenny | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 3,871 | 0 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Patrick McIlvenny | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 2,198 | 2,198 | - | - | Restricted Stock Units (RSU) | |
| Horizon Therapeutics Plc | Patrick McIlvenny | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2023 | 1,904 | 3,809 | - | - | Restricted Stock Units (RSU) |